|Day Low/High||0.03 / 0.04|
|52 Wk Low/High||0.01 / 0.06|
Four posters describing the Company's platform to be presented, including a third-party clinical study poster of the Stool Bacterial Pathogens Panel
New patent extends protection to all the Company's assays; Company to explore licensing opportunities with non-competing entities
Assay for Bordetella pertussis, or whooping cough, shipping to U.S. customers; Company also announces CE Marking
Eliminates variable-price mandatory conversion feature
Company also has more than 40 sites in the U.S. currently evaluating or committed to evaluate under Investigational Use Only (IUO) labeling
Technology shown to distinguish disease-causing potentially life-threatening Staphylococcus strains from Staphylococcus present due to environmental contamination, supporting more accurate diagnosis, better patient care and healthcare cost savings
Sample-to-result test for Bordetella pertussis, or whooping cough, receives clearance in fewer than 60 days from submission
Senior Director of Regulatory and Clinical Affairs recognized for scientific leadership and career accomplishments
Multicenter evaluation demonstrates Staph ID/R Blood Culture Panel's efficacy in rapid identification of Staphylococci and detection of mecA gene
Study validates that Great Basin's assay provides cost effective, rapid and definitive detection of Shiga Toxin-producing E.coli
Upon FDA clearance, Company's sample-to-result test will offer cost effective and easy-to-use testing for Bordetella pertussis or whooping cough
Company determines additional funding likely unnecessary to meet 2017 needs
Company Stock Trades Under GBSND for 20 Days; Reverts to GBSN After
Company has 663,334 shares of common stock outstanding post-split; 1,500,000,000 authorized shares
Board of Directors Approve 1-for-300 Reverse Stock Split and Sets Effective Date for Reverse Stock Split and Authorized Share Increase
Upon anticipated FDA clearance, Company's syndromic panel will provide cost effective identification for common gastrointestinal pathogens
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.